The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index; none of the 21 sources its claims cite is checked for support yet.
Telomere dysfunction induces metabolic and mitochondrial compromise
Open accessAbstract
Telomere dysfunction activates p53-mediated cellular growth arrest, senescence and apoptosis to drive progressive atrophy and functional decline in high-turnover tissues. The broader adverse impact of telomere dysfunction across many tissues including more quiescent systems prompted transcriptomic network analyses to identify common mechanisms operative in haematopoietic stem cells, heart and liver. These unbiased studies revealed profound repression of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha and beta (PGC-1α and PGC-1β, also known as Ppargc1a and Ppargc1b, respectively) and the downstream network in mice null for either telomerase reverse transcriptase (Tert) or telomerase RNA component (Terc) genes. Consistent with PGCs as master regulators of mitochondrial physiology and metabolism, telomere dysfunction is associated with impaired mitochondrial biogenesis and function, decreased gluconeogenesis, cardiomyopathy, and increased reactive oxygen species. In the setting of telomere dysfunction, enforced Tert or PGC-1α expression or germline deletion of p53 (also known as Trp53) substantially restores PGC network expression, mitochondrial respiration, cardiac function and gluconeogenesis. We demonstrate that telomere dysfunction activates p53 which in turn binds and represses PGC-1α and PGC-1β promoters, thereby forging a direct link between telomere and mitochondrial biology. We propose that this telomere–p53–PGC axis contributes to organ and metabolic failure and to diminishing organismal fitness in the setting of telomere dysfunction.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Telomere dysfunction in mice represses PGC-1α and PGC-1β through p53, impairing mitochondrial function and metabolism. This telomere–p53–PGC pathway links telomere attrition to cardiomyopathy, defective gluconeogenesis, and stem cell decline.
Key findings
- Transcriptomic profiling of haematopoietic stem cells, heart, and liver from G4 Tert−/− mice showed broad repression of the PGC-1α/β network, including oxidative phosphorylation, oxidative defence, gluconeogenesis, fatty acid/cholesterol synthesis, and β-oxidation genes; RT–qPCR and western blot confirmed lower PGC-1α/β and targets such as NRF-1, ERRα, PPARα, and TFAM.
- Mitochondrial consequences included reduced mitochondrial DNA content and density, lower complex I and IV activity, decreased state III respiration, reduced uncoupled respiration in G4 liver and heart (31% and 25%, respectively), lower ATP synthesis/content, and increased ROS/H2O2 production.
- G4 mice developed dilated cardiomyopathy by 15 months, showed a 30% drop in plasma glucose after 12 h fasting, and had impaired HSC reconstitution; adenoviral Tert partially restored PGC targets and raised glucose by 30% in vivo and 80% in cultured G4 hepatocytes, while adenoviral PGC-1α increased state III and IV respiration in G4 liver mitochondria by 3.1-fold and 3.2-fold.
- p53 deficiency restored PGC expression and mitochondrial DNA copy number; p53–ER activation repressed PGCs and reduced mitochondrial mass by 10–15%; p53 bound PGC-1α/β promoters and repressed reporters fivefold; p53 loss improved fractional shortening by 30% in a doxorubicin cardiomyopathy protocol.
Methods
- Used Tert−/− mice across WT, G1, and G4 generations, Terc−/− G2 mice, and p53−/− backgrounds; profiled HSCs, liver, and heart by microarray with SAM or fold-change analysis and Ingenuity pathway analysis, followed by RT–qPCR and western blot.
- Assessed mitochondrial and metabolic phenotypes via qPCR-based mtDNA quantification, HPLC ATP measurement, Seahorse XF24 and Clark electrode respiration, ROS and carbonylated protein assays, fasting glucose, hepatocyte gluconeogenesis, echocardiography, and competitive transplantation.
- Mechanistic tests included adenoviral Tert or PGC-1α delivery, p53–ER MEF activation, PGC promoter luciferase reporters, anti-p53 chromatin immunoprecipitation, and doxorubicin-induced cardiomyopathy.
Limitations
- No dedicated limitations section is present; the authors state that the relative contributions of DNA damage checkpoints versus metabolic/mitochondrial dysfunction require further study, and that p53-mediated PGC repression is context-dependent.
- Evidence comes from mouse genetic models and cell systems, with no human data; germline p53 deletion and adenoviral overexpression may introduce pleiotropic or context-specific effects.
- The ROS scavenger N-acetylcysteine did not rescue defective HSC repopulation, indicating increased ROS is not central to HSC failure, although its role in other phenotypes is not fully resolved.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 21 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This impaired mitochondrial ATP synthesis is associated with decreased total ATP content in G4 hearts and livers (Fig. 2d).”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction decreases mitochondrial mass and energy production
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This Ad-PGC-1α impact was markedly more pronounced in G4 mice than in WT mice or hepatocytes.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction induces pathophysiologies classical for impaired PGC function
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“cultured G4 hepatocytes which show an 80% increase in glucose output relative to Ad-GFP controls”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction induces pathophysiologies classical for impaired PGC function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“respiration uncoupled from ATP synthesis (induced by 2,4-dinitrophenol, DNP) was also reduced in G4 liver and heart mitochondria (31% and 25%, respectively)”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction decreases mitochondrial mass and energy production
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Functionally, telomere dysfunction correlated with a marked decline in complex I and IV activity when assayed with either whole tissue lysates or isolated mitochondria from G1 and G4 heart and liver tissues”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction decreases mitochondrial mass and energy production
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“G4 mice also showed decreased blood triglyceride and cholesterol levels”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction represses PGC network and mitochondrial biogenesis
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Additionally, complex II- and complex IV-dependent respiration was also decreased in G4 mitochondria”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction decreases mitochondrial mass and energy production
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Telomere dysfunction transcriptomes showed strong enrichment for networks regulated by PGC-1α and PGC-1β including oxidative phosphorylation (OXPHOS), mitochondrial function, oxidative stress and gluconeogenesis”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction represses PGC network and mitochondrial biogenesis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: The transcriptomic network analyses used in this study were unbiased.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“while running endurance capacity was significantly reduced in G4 mice”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction represses PGC network and mitochondrial biogenesis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Ad-Tert had no effect on gluconeogenesis in WT mice”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction induces pathophysiologies classical for impaired PGC function
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 22
- Probably not a substantial claim. 5
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“G4 mice also exhibited an inability to maintain plasma glucose levels under fasting conditions, experiencing a marked 30% drop at 12 h of fasting, yet maintained normal plasma glucose levels under fed conditions”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction induces pathophysiologies classical for impaired PGC function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In this model, progressive telomere shortening is associated with increasing atrophy and functional decline across proliferative organs (intestinal, haematopoietic) and equally profound impairment in relatively quiescent organs (liver and heart) that do not exhibit significant levels of apoptosis”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction represses PGC network and mitochondrial biogenesis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“as well as reductions in PGC and targets, mitochondrial DNA content, complex I and IV activity, and ATP levels”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction decreases mitochondrial mass and energy production
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Body composition analysis showed body weight reduction and striking decrease in fat mass with preserved lean mass, yet no differences in spontaneous activity or food intake were apparent”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction represses PGC network and mitochondrial biogenesis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“this PGC-mitochondrial link is supported by Ad-PGC-1α-induced rescue of gluconeogenesis in vivo and in vitro in G4 hepatocytes”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction induces pathophysiologies classical for impaired PGC function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“G4 Tert−/− mice exhibited these classical signs of impaired PGC function, including an age-progressive dilated cardiomyopathy with left ventricular wall thinning, increased left ventricular diameter, and reduced fractional shortening by 15 months of age”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction induces pathophysiologies classical for impaired PGC function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We documented reduced mitochondrial DNA content (Fig. 2a) and reduced mitochondrial density in G1 and G4 heart and liver”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction decreases mitochondrial mass and energy production
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“which aligned with increased ROS levels by FACS in HSCs and increased carbonylated proteins in liver homogenates”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction decreases mitochondrial mass and energy production
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“WT MEF or heart tissues of mice treated with the DNA damage agent doxorubicin showed increased p53 levels after 24 h and coincident binding of p53 to PGC-1α promoter and repression of PGC-1α levels”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > p53 directly represses PGC-1α and PGC-1β
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“anti-p53 chromatin-immunoprecipitation assays in G2 Terc−/− p53+/+, but not G2 Terc−/− p53−/−, MEFs demonstrated physical binding between p53 and (1) PGC-1α fragments containing p53 binding elements at −564 and −954, but not −2317, and (2) PGC1β fragments containing p53 binding elements at −1616 and −1030”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > p53 directly represses PGC-1α and PGC-1β
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“after 48 h of OHT treatment, G2 Terc−/− p53−/− p53–ER MEFs showed a 10–15% decrease in mitochondrial mass compared with no significant change in the OHT-treated G2 Terc−/− p53−/− controls”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > p53 directly represses PGC-1α and PGC-1β
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Increasing dosage of p53 in either p53−/− or G2 p53−/− MEFs showed repressed PGC-1α and PGC-1β levels and increasing occupancy of p53 binding elements in PGC-1α and PGC-1β promoters”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > p53 directly represses PGC-1α and PGC-1β
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Taken together, these collective data establish that telomere-dysfunction-induced repression of the PGC network is associated with mitochondrial dysfunction as evidenced by compromised OXPHOS and respiration, decreased ATP generation capacity, and increased oxidative stress.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction decreases mitochondrial mass and energy production
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In summary, multiple levels of evidence establish telomere dysfunction-induced p53 represses PGC-1α and PGC-1β, thereby linking telomeres to mitochondrial biology, oxidative defence, and metabolism.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Discussion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We demonstrate that telomere dysfunction activates p53 which in turn binds and represses PGC-1α and PGC-1β promoters, thereby forging a direct link between telomere and mitochondrial biology.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In the absence of telomerase, continued cell division results in telomere shortening, loss of ‘capping’ function, and p53 activation12-15.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Abstract
What the sources say
- Not checked yetcites [12] Hastie, N. D. et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866–868 (1990) source
- Not checked yetcites [13] Lee, H.-W. et al. Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569–574 (1998) source
- Not checked yetcites [14] Blasco, M. A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25–34 (1997) source
- Not checked yetcites [15] Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527–538 (1999) source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We propose that this telomere–p53–PGC axis contributes to organ and metabolic failure and to diminishing organismal fitness in the setting of telomere dysfunction.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We propose that telomere dysfunction-induced repression of the PGC network and consequent mitochondriopathy and metabolic changes, along with telomere-induced apoptotic and proliferative checkpoints, contributes to functional multi-system decline in the setting of telomere dysfunction.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Discussion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“p53 deficiency markedly attenuates the degenerative phenotypes associated with telomere dysfunction, whereas constitutively activated p53 accelerates ageing phenotypes15-18.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > p53 directly represses PGC-1α and PGC-1β
What the sources say
- Not checked yetcites [15] Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527–538 (1999) source
- Not checked yetcites [16] Wong, K. K. et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 421, 643–648 (2003) source
- Not checked yetcites [17] Maier, B. et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev. 18, 306–319 (2004) source
- Not checked yetcites [18] Tyner, S. D. et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 415, 45–53 (2002) source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“The relevance of PGCs to age-related pathologies may stem from their regulation of mitochondrial biogenesis and control of metabolic processes (gluconeogenesis, fatty acid metabolism and β-oxidation), processes that relate to increased insulin resistance and diabetes in the aged9.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Abstract
What the sources say
- Not checked yetcites [9] Lin, J., Handschin, C. & Spiegelman, B. M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 1, 361–370 (2005) source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“prompted by studies linking impaired mitochondrial function to defective HSC maintenance27-29”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction induces pathophysiologies classical for impaired PGC function
What the sources say
- Not checked yetcites [27] Pannicke, U. et al. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nature Genet. 41, 101–105 (2008) source
- Not checked yetcites [28] Sankaran, V. G., Orkin, S. H. & Walkley, C. R. Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. Genes Dev. 22, 463–475 (2008) source
- Not checked yetcites [29] Liu, J. et al. Bmi1 regulates mitochondrial function and the DNA damage response pathway. Nature 459, 387–392 (2009) source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Telomere dysfunction activates p53-mediated cellular growth arrest, senescence and apoptosis to drive progressive atrophy and functional decline in high-turnover tissues.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Previous work has established that repression of either or both co-activators (PGC-1α or PGC-1β) decreases mitochondrial biogenesis and function, elicits cardiomyopathy and impairs de novo glucose production23-25.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction induces pathophysiologies classical for impaired PGC function
What the sources say
- Not checked yetcites [23] Arany, Z. et al. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-γ coactivator 1α. Proc. Natl Acad. Sci. USA 103, 10086–10091 (2006) source
- Not checked yetcites [24] Yoon, J. C. et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413, 131–138 (2001) source
- Not checked yetcites [25] Lai, L. et al. Transcriptional coactivators PGC-1α and PGC-lβ control overlapping programs required for perinatal maturation of the heart. Genes Dev. 22, 1948–1961 (2008) source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“qPCR-based mitochondrial quantification was performed with two different primer sets for genomic and mitochondrial loci.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > METHODS SUMMARY
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“For chromatin immunoprecipitation, we followed the EZ-Chip protocol (Promega) using p53 specific antibody and control IgG.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > METHODS SUMMARY
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
N-acetylcysteine given from birth effectively scavenges reactive oxygen species in the haematopoietic stem cell compartments of G1 and G4 mice.
“G1 or G4 mice treated from birth with N-acetylcysteine, a ROS scavenger, did not rescue defective HSC repopulation in competitive transplantations”
The paper relies on this without support.
The G2 Terc−/− mice used have a degree of telomere dysfunction comparable to that of G4 Tert−/− mice.
“G2 Terc−/− liver and hearts (exhibiting comparable telomere dysfunction as G4 Tert−/− mice)”
The paper relies on this without support.
The transcriptomic network analyses used in this study were unbiased.
“These unbiased studies revealed profound repression of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha and beta”
The paper relies on this without support.
The p53 binding elements identified in the PGC-1α and PGC-1β promoters are the functional sites through which p53 represses these genes.
“anti-p53 chromatin-immunoprecipitation assays in G2 Terc−/− p53+/+, but not G2 Terc−/− p53−/−, MEFs demonstrated physical binding between p53 and (1) PGC-1α fragments containing p53 binding elements at −564 and −954, but not −2317, and (2) PGC1β fragments containing p53 binding elements at −1616 and −1030”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TERC−/− mice present altered mitochondrial functions, including increased production of reactive oxygen species (ROS) from the electron transfer chain (ETC) (Passos et al., 2010; Sahin et al., 2011).”
From P66SHC deletion improves fertility and progeric phenotype of late-generation TERC-deficient mice but not their short lifespan (2016) · cites this paper as Sahin et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, other mutations in genes involved in ROS metabolism, such as SOD2 haploinsufficiency, do not cooperate with telomere dysfunction (Guachalla et al., 2009), and the treatment with N‐acetylcysteine does not rescue progeric phenotypes of late‐generation TERT‐deficient mice (Sahin et al., 2011).”
From P66SHC deletion improves fertility and progeric phenotype of late-generation TERC-deficient mice but not their short lifespan (2016) · cites this paper as Sahin et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The increase in telomere length in quiescent/differentiated tissues could be related to prevention of stress-dependent telomere shortening (Sahin et al, 2011; Sharma et al, 2003), or to re-population of tissues by cells with longer telomeres (Hao et al, 2005).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Sahin et al, 2011
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In mouse models of accelerated telomere shortening, critically short telomeres have been shown to repress PGC1‐α‐ and β‐mediated mitochondrial biogenesis (Sahin et al, 2011; Chang et al, 2016).”
From Length-independent telomere damage drives post-mitotic cardiomyocyte senescence (2019) · cites this paper as Sahin et al, 2011
The cited source says what the claim attributes to it.
In the citing paper
“Although the rates of stem cell replenishment are unlike to completely account for the telomere length differences observed, we cannot discard other roles of telomerase such as the rescue of telomere shortening through stress protection (Saretzki, 2009) or the recently association to mitochondrial protection in post mitotic tissues (Sahin et al, 2011).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Sahin et al, 2011
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“our sample sizes are similar to those reported in previous publications.15,24,86”
From TERT activation targets DNA methylation and multiple aging hallmarks (2024) · cites this paper as [24]
Experimental — accuracy not yet measuredIn the citing paper
“signaling downstream of short telomeres activates p53, which binds and represses PGC-1α and PGC-1β promoters leading to mitochondrial dysfunction (Sahin et al., 2011).”
From Telomeres and cell senescence—size matters not (2017) · cites this paper as Sahin et al., 2011
In the citing paper
“It is interesting that telomere dysfunction has been associated with changes in mitochondrial metabolism (93)”
From Causes, consequences, and reversal of immune system aging (2013) · cites this paper as [93]
In the citing paper
“more recently it has been recognized that telomere dysfunction causes prominent phenotypes in slow-turnover tissues97,99,100,103 (Table 2).”
From The telomere syndromes (2012) · cites this paper as [103]
In the citing paper
“The telomerase-knockout mouse has provided an important model for understanding telomere-mediated disease mechanisms because there is a remarkable convergence with human disease phenotypes (an overview is shown in Table 2)36,82,84,85,97,99–111.”
From The telomere syndromes (2012) · cites this paper as [103]
In the citing paper
“In these tissues, the metabolic dysfunction appears to be due to the effect of downregulation of PGC1α, which is a transcriptional co-activator that is important for mitochondrial biogenesis103.”
From The telomere syndromes (2012) · cites this paper as [103]
In the citing paper
“Shortened dysfunctional telomeres in other mouse cell types, such as cardiac myocytes and hepatocytes, have also been associated with decreased mitochondrial copy number and defective oxidative metabolism103.”
From The telomere syndromes (2012) · cites this paper as [103]
In the citing paper
“Recent findings correlate deficiency of TERT (and subsequent loss of telomeres) with deficiencies in mitochondrial function attributed to decreases in PGC-1α and PGC-1β expression and suppressed mitochondrial biogenesis (364).”
From Redox regulation of mitochondrial function (2012) · cites this paper as [364]
In the citing paper
“p53 activation was found to suppress expression of the PGC-1α and PGC-1β (364), thus linking telomeres to mitochondrial biogenesis.”
From Redox regulation of mitochondrial function (2012) · cites this paper as [364]
In the citing paper
“Cellular senescence is thought to further propagate nearby tissue aging through intracellular metabolic compromise (eg, mitochondrial dysfunction) (Sahin et al, 2011) and altered production of secretory factors that promote aging by increasing degradation of nearby tissue and sterile inflammation (Coppe et al, 2010a, b;Freund et al, 2010) (ie, senescence-associated secretory phenotype, SASP).”
From Sleep health: Reciprocal regulation of sleep and innate immunity (2017) · cites this paper as Sahin et al, 2011
In the citing paper
“For example, the tumor suppressor protein, p53, may be activated, which inhibits oxidative defense mechanisms (such as peroxisome proliferator-activated receptor-gamma coactivator [PGC] 1-α and β, promoting mitochondrial damage and senescence or apoptosis (Sahin et al., 2011) (Fig. 2).”
From Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging (2015) · cites this paper as Sahin et al., 2011
Citations
Cites
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734
Metabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationUnderstanding the odd science of aging
Kirkwood, T. B. L. (2005) · Cell · doi:10.1016/j.cell.2005.01.027 · Cited by 1,984
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 999
Catic, A. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.12.003 · Cited by 58
Small-Molecule-Targeting Hairpin Loop of hTERT Promoter G-Quadruplex Induces Cancer Cell Death
Song, J. H., Kang, H.-J., Luevano, L. A., Gokhale, V. M., Wu, K., Pandey, R., Chow, H. ‐. S., Hurley, L. H., & Kraft, A. S. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.04.009 · Cited by 58
Kelly, D. P. (2011) · Nature · doi:10.1038/nature09896 · Cited by 62
Telomere length and cardiovascular disease risk
Zhan, Y., & Hägg, S. (2019) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000613 · Cited by 57
Bourgognon, J.-M., Spiers, J. G., Robinson, S. W., Scheiblich, H., Glynn, P., Ortori, C. A., Bradley, S. J., Tobin, A. B., & Steinert, J. R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009579118 · Cited by 57
Kobayashi, M., Deguchi, Y., Nozaki, Y., & Higami, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116025 · Cited by 63
Radiation interactions with biological systems
Islam, M. T. (2017) · International Journal of Radiation Biology · doi:10.1080/09553002.2017.1286050 · Cited by 60
Parkin does not prevent accelerated cardiac aging in mitochondrial DNA mutator mice
Woodall, B. P., Orogo, A. M., Najor, R. H., Cortez, M. Q., Moreno, E. R., Wang, H., Divakaruni, A. S., Murphy, A. N., & Gustafsson, Å. B. (2019) · JCI Insight · doi:10.1172/jci.insight.127713 · Cited by 55
Age-related changes of myocardial ATP supply and demand mechanisms
Yaniv, Y., Juhaszova, M., & Sollott, S. J. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.06.001 · Cited by 56
Jang, J. E., Ko, M. S., Yun, J.-Y., Kim, M., Kim, J. H., Park, H. S., Kim, A.-R., Kim, H.-J., Kim, B. J., Ahn, Y. E., et al. (2016) · Diabetes · doi:10.2337/db15-1624 · Cited by 59
Aberrant telomere length and mitochondrial DNA copy number in suicide completers
Otsuka, I., Izumi, T., Boku, S., Kimura, A., Zhang, Y., Mouri, K., Okazaki, S., Shiroiwa, K., Takahashi, M., Ueno, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03599-8 · Cited by 63
RETRACTED: New intranasal and injectable gene therapy for healthy life extension
Jaijyan, D. K., Selariu, A., Cruz-Cosme, R., Tong, M., Yang, S., Stefa, A., Kekich, D., Sadoshima, J., Herbig, U., Tang, Q., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121499119 · Cited by 57
RetractedNeto, I. V. D. S., Pinto, A. P., Muñoz, V. R., Marqueti, R. D. C., Pauli, J. R., Ropelle, E. R., & da Silva, A. S. R. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101935 · Cited by 56
Antiaging Strategies and Remedies: A Landscape of Research Progress and Promise
Tenchov, R., Sasso, J. M., Wang, X., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00532 · Cited by 62
Telomere function and regulation from mouse models to human ageing and disease
Jones-Weinert, C. W., Mainz, L., & Karlseder, J. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00800-5 · Cited by 63
Osteoarthritis and telomere shortening
Kuszel, Ł., Trzeciak, T., Richter, M., & Czarny‐Ratajczak, M. (2014) · Journal of Applied Genetics · doi:10.1007/s13353-014-0251-8 · Cited by 55
Lamb, R., Ózsvári, B., Bonuccelli, G., Smith, D. L., Pestell, R. G., Martinez‐Outschoorn, U., Clarke, R. B., Sotgia, F., & Lisanti, M. P. (2015) · Oncotarget · doi:10.18632/oncotarget.5260 · Cited by 55
Belsky, J., & Shalev, I. (2016) · Development and Psychopathology · doi:10.1017/s0954579416000900 · Cited by 58
Bonuccelli, G., Peiris‐Pagès, M., Ózsvári, B., Martinez‐Outschoorn, U., Sotgia, F., & Lisanti, M. P. (2016) · Oncotarget · doi:10.18632/oncotarget.14196 · Cited by 55
Associations Between Cellular Aging Markers and Metabolic Syndrome: Findings From the CARDIA Study
Révész, D., Verhoeven, J. E., Picard, M. A., Lin, J., Sidney, S., Epel, E. S., Penninx, B. W. J. H., & Puterman, E. M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01625 · Cited by 55
The mitochondria in lung fibrosis: friend or foe?
Malsin, E. S., & Kamp, D. W. (2018) · Translational research · doi:10.1016/j.trsl.2018.05.005 · Cited by 56
Lv, N., Zhao, Y., Liu, X., Ye, L., Liang, Z., Kang, Y., Dong, Y., Wang, W., Kolliputi, N., & Shi, L. (2022) · Aging Cell · doi:10.1111/acel.13594 · Cited by 59
Reduced telomere length in neurodegenerative disorders may suggest shared biology
Kota, L. N., Bharath, S., Purushottam, M., Moily, N. S., Sivakumar, P. T., Varghese, M., Pal, P. K., & Jain, S. (2015) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.13100240 · Cited by 53
Tümpel, S., & Rudolph, K. L. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06547.x · Cited by 59
Role of p53 Within the Regulatory Network Controlling Muscle Mitochondrial Biogenesis
Saleem, A., Carter, H. N., Iqbal, S., & Hood, D. A. (2011) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e31822d71be · Cited by 55
Telomere dysfunction instigates inflammation in inflammatory bowel disease
Chakravarti, D., Lee, R., Multani, A. S., Santoni, A., Keith, Z., Hsu, W., Chang, K., Reyes-Uribe, L., Rashid, A., Wu, C., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024853118 · Cited by 54
Self-citationCancer-specific loss of TERT activation sensitizes glioblastoma to DNA damage
Amen, A. M., Fellmann, C., Soczek, K. M., Ren, S. M., Lew, R. J., Knott, G. J., Park, J. E., McKinney, A., Mancini, A., Doudna, J. A., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008772118 · Cited by 53
Correcting magnesium deficiencies may prolong life
Rowe, W. J. (2012) · Clinical Interventions in Aging · doi:10.2147/cia.s28768 · Cited by 53
Aubert, G. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00004-9 · Cited by 57
The role of the mtDNA set point in differentiation, development and tumorigenesis
Sun, X., & John, J. C. S. (2016) · Biochemical Journal · doi:10.1042/bcj20160008 · Cited by 55
Kim, K. S., Kwak, J. W., Lim, S. J., Park, Y. K., Yang, H. S., & Kim, H. J. (2016) · Aging and Disease · doi:10.14336/ad.2016.0215 · Cited by 53
Precancer in Ulcerative Colitis: The Role of the Field Effect and its Clinical Implications
Baker, K. T., Salk, J. J., Brentnall, T. A., & Risques, R. A. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx117 · Cited by 56
Ling, X., Wang, Y., Zou, P., Zhang, G., Wang, Z., Zhang, X., Chen, H., Peng, K., Han, F., Liu, J., et al. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2017.12.099 · Cited by 53
Self-citationThe clock is ticking: the impact of ageing on T cell metabolism
Quinn, K. M., Palchaudhuri, R., Palmer, C. S., & Gruta, N. L. L. (2019) · Clinical & Translational Immunology · doi:10.1002/cti2.1091 · Cited by 52
Chang, A. C. Y., Pardon, G., Chang, A. C. H., Wu, H., Ong, S., Eguchi, A., Ancel, S., Holbrook, C., Ramunas, J., Ribeiro, A. J. S., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.04.018 · Cited by 54
The Review of Anti-aging Mechanism of Polyphenols on Caenorhabditis elegans
Liu, L., Guo, P., Wang, P., Zheng, S., Qu, Z., & Liu, N. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.635768 · Cited by 52
Cardiovascular aging: spotlight on mitochondria
Ali, M. A., Gioscia‐Ryan, R. A., Yang, D., Sutton, N. R., & Tyrrell, D. J. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00632.2023 · Cited by 54
Aging in Rothmund-Thomson syndrome and related RECQL4 genetic disorders
Lu, L., Jin, W., & Wang, L. L. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.06.002 · Cited by 55
Premature senescence of cardiac fibroblasts and atrial fibrosis in patients with atrial fibrillation
Xie, J., Chen, Y., Hu, C., Pan, Q., Wang, B., Li, X., Geng, J., & Xu, B. (2017) · Oncotarget · doi:10.18632/oncotarget.19853 · Cited by 54
Mitochondrial function in skeletal myofibers is controlled by a TRF2‐SIRT3 axis over lifetime
Robin, J. D., Burbano, M. S. J., Peng, H., Croce, O., Thomas, J. L., Laberthonnìère, C., Renault, V. M., Lototska, L., Pousse, M., Tessier, F., et al. (2020) · Aging Cell · doi:10.1111/acel.13097 · Cited by 58
Stabilization of telomere by the antioxidant property of polyphenols: Anti-aging potential
Maleki, M., Khelghati, N., Alemi, F., Bazdar, M., Asemi, Z., Majidinia, M., Sadeghpoor, A., Mahmoodpoor, A., Jadidi‐Niaragh, F., Targhazeh, N., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118341 · Cited by 53
NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity
Amin, S., Aktar, S., Rahman, M. M., & Chowdhury, M. M. H. (2022) · Microbes and Infection · doi:10.1016/j.micinf.2021.104913 · Cited by 51
Therapeutic opportunities for senolysis in cardiovascular disease
Sweeney, M. D., Cook, S. A., & Gil, J. (2022) · FEBS Journal · doi:10.1111/febs.16351 · Cited by 54
Gamma rays induce a p53-independent mitochondrial biogenesis that is counter-regulated by HIF1α
Bartoletti‐Stella, A., Mariani, E., Kurelac, I., Maresca, A., Caratozzolo, M. F., Iommarini, L., Carelli, V., Eusebi, L. H., Guido, A., Cenacchi, G., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.187 · Cited by 52
Nutrient availability links mitochondria, apoptosis, and obesity
Pintus, F., Floris, G., & Rufini, A. (2012) · Aging · doi:10.18632/aging.100505 · Cited by 51
Calado, R. T., & Young, N. S. (2012) · F1000 Medicine Reports · doi:10.3410/m4-8 · Cited by 55
Karell, P., Bensch, S., Ahola, K., & Asghar, M. (2017) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2017.1127 · Cited by 51
Telomere Homeostasis: Interplay with Magnesium
Maguire, D., Neytchev, O., Talwar, D., McMillan, D., & Shiels, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010157 · Cited by 50
Interference between PARPs and SIRT1: a novel approach to healthy ageing?
Cantó, C., & Auwerx, J. H. (2011) · Aging · doi:10.18632/aging.100326 · Cited by 50
Campa, D., Barrdahl, M., Santoro, A., Severi, G., Baglietto, L., Omichessan, H., Tumino, R., Bueno-de-Mesquita, H. B., Peeters, P. H. M., Weiderpass, E., et al. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0955-5 · Cited by 51
Vos, S., Nawrot, T. S., Martens, D. S., Byun, H., & Janssen, B. G. (2020) · Epigenetics · doi:10.1080/15592294.2020.1790923 · Cited by 50
Velichkovska, M., Surnar, B., Nair, M., Dhar, S., & Toborek, M. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01014 · Cited by 49
Kröller‐Schön, S., Jansen, T., Schüler, A., Oelze, M. W., Wenzel, P., Hausding, M., Kerahrodi, J. G., Beisele, M., Lackner, K. J., Daiber, A., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301717 · Cited by 49
Targeting DNA-PKcs and telomerase in brain tumour cells
Gurung, R. L., Lim, H. K., Venkatesan, S., Lee, P. S. W., & Hande, M. P. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-232 · Cited by 49
Mitochondrial DNA copy number is associated with psychosis severity and anti-psychotic treatment
Kumar, P., Efstathopoulos, P., Millischer, V., Olsson, E., Wei, Y. B., Brüstle, O., Schalling, M., Villaescusa, J. C., Ösby, U., & Lavebratt, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-31122-0 · Cited by 49
Long noncoding RNA in cardiac aging and disease
Lozano‐Vidal, N., Bink, D. I., & Boon, R. A. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz046 · Cited by 50
Hou, J., Yin, W., Li, P., Chen, H., Xu, T., Cheng, J., Li, T., Wang, L., Yu, Z., & Yuan, J. (2019) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.121663 · Cited by 49
Song, N., Li, Z., Qin, N., Howell, C. R., Wilson, C. L., Easton, J. B., Mulder, H. L., Edmonson, M. N., Rusch, M., Zhang, J., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2503 · Cited by 50
Physical activity, a modulator of aging through effects on telomere biology
Semeraro, M. D., Smith, C., Kaiser, M., Levinger, I., Duque, G., Gruber, H. J., & Herrmann, M. (2020) · Aging · doi:10.18632/aging.103504 · Cited by 50
Saccharomyces cerevisiae as a Model to Study Replicative Senescence Triggered by Telomere Shortening
Teixeira, M. T. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00101 · Cited by 54
Handbook of the Biology of Aging
Watt, D. F. (2012) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acr108 · Cited by 49
Li, L., Zhang, H., Chen, B., Xia, B., Zhu, R., Liu, Y., Dai, X., Ye, Z., Zhao, D., Mo, F., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114653 · Cited by 49
Asghar, M., Odeh, A., Fattahi, A. J., Henriksson, A. E., Miglar, A., Khosousi, S., & Svenningsson, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-22400-z · Cited by 50
Carlquist, J. F., Knight, S., Cawthon, R., Le, V. T., Bunch, T. J., Horne, B. D., Rollo, J. S., Huntinghouse, J. A., Muhlestein, J. B., & Anderson, J. L. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.07.032 · Cited by 49
Cellular senescence determines endothelial cell damage induced by uremia
Carracedo, J., Buendía, P., Merino, A. M., Soriano, S., de Motta, E. E., Martín‐Malo, A., Aljama, P., & Ramı́rez, R. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.04.004 · Cited by 48
Sun, L.-Y., Wang, N., Ban, T., Sun, Y.-H., Han, Y., Sun, L., Yan, Y., Kang, X., Chen, S., Sun, L., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.06.012 · Cited by 48
Differential Protein Distribution between the Nucleus and Mitochondria: Implications in Aging
Lionaki, E., Gkikas, I., & Tavernarakis, N. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00162 · Cited by 51
Criscuolo, F., Smith, S., Zahn, S., Heidinger, B. J., & Haussmann, M. F. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0440 · Cited by 49
Martens, D. S., & Nawrot, T. S. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.06.1213 · Cited by 47
From cellular senescence to age-associated diseases: the miRNA connection
Schraml, E., & Grillari, J. (2012) · Longevity & Healthspan · doi:10.1186/2046-2395-1-10 · Cited by 47
Mitochondrial Dysfunction in Cardiac Arrhythmias
Deng, J., Jiang, Y., Chen, Z. B., Rhee, J., Deng, Y., & Wang, Z. V. (2023) · Cells · doi:10.3390/cells12050679 · Cited by 53
Sui, B., Hu, C., & Jin, Y. J. (2015) · Biogerontology · doi:10.1007/s10522-015-9609-5 · Cited by 47
DNA Damage Responses and Oxidative Stress in Dyskeratosis Congenita
Pereboeva, L., Westin, E. R., Patel, T., Flaniken, I. Z., Lamb, L. S., Klingelhutz, A. J., & Goldman, F. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076473 · Cited by 48
ArabidopsisATM and ATR Kinases Prevent Propagation of Genome Damage Caused by Telomere Dysfunction
Amiard, S., Depeiges, A., Allain, E., White, C. I., & Gallego, M. E. (2011) · The Plant Cell · doi:10.1105/tpc.111.092387 · Cited by 47
Mitochondrial Functions Are Compromised in CD4 T Cells From ART-Controlled PLHIV
Zhao, J., Schank, M., Wang, L., Li, Z., Nguyen, L. N., Dang, X., Cao, D., Khanal, S., Nguyen, L. N. T., Thakuri, B. K. C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658420 · Cited by 47
Senolytic therapeutics: An emerging treatment modality for osteoarthritis
Ansari, M. M., Ghosh, M., Lee, D., & Son, Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102275 · Cited by 49
Mitochondrial Alterations During Carcinogenesis
Wang, X., Peralta, S., & Moraes, C. T. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00004-6 · Cited by 47
Missios, P., Zhou, Y., Guachalla, L. M., von Figura, G., Wegner, A., Chakkarappan, S. R., Binz, T. M., Gompf, A., Hartleben, G., Burkhalter, M. D., et al. (2014) · Nature Communications · doi:10.1038/ncomms5924 · Cited by 49
Evaluating biomarkers to model cancer risk post cosmic ray exposure
Sridharan, D. M., Asaithamby, A., Blattnig, S. R., Costes, S. V., Doetsch, P. W., Dynan, W. S., Hahnfeldt, P., Hlatky, L., Kidane, Y., Kronenberg, A., et al. (2016) · Life Sciences in Space Research · doi:10.1016/j.lssr.2016.05.004 · Cited by 46
The Telomeric Complex and Metabolic Disease
Kirchner, H., Shaheen, F., Kalscheuer, H., Schmid, S. M., Oster, H., & Lehnert, H. (2017) · Genes · doi:10.3390/genes8070176 · Cited by 46
Cai, Y., Kandula, V., Kosuru, R., Ye, X., Irwin, M. G., & Xia, Z. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1371886 · Cited by 46
Schank, M., Zhao, J., Wang, L., Li, Z., Cao, D., Nguyen, L. N., Dang, X., Khanal, S., Nguyen, L. N. T., Thakuri, B. K. C., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03238-7 · Cited by 47
Mitochondrial regulation during male germ cell development
Wang, X., Yin, L., Wen, Y., & Yuan, S. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04134-3 · Cited by 50
Brandt, M., Doerschmann, H., Khraisat, S., Knopp, T., Ringen, J., Kalinovic, S., Garlapati, V. S., Siemer, S., Molitor, M., Göbel, S., et al. (2022) · Hypertension · doi:10.1161/hypertensionaha.121.18935 · Cited by 47
The Molecular Mechanism of Polyphenols in the Regulation of Ageing Hallmarks
Pereira, Q. C., dos Santos, T. W., Fortunato, I. M., & Ribeiro, M. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065508 · Cited by 51
Gene expression in the Parkinson's disease brain
Lewis, P. A., & Cookson, M. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.11.016 · Cited by 45
Cheng, Y.-Y., Kao, T., Chang, Y., Wu, C., Peng, T., Wu, L., Yang, H., Liaw, F., & Chen, W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180687 · Cited by 45
Mitochondrial dysfunction and chronic lung disease
Fang, T., Wang, M., Xiao, H., & Wei, X. (2019) · Cell Biology and Toxicology · doi:10.1007/s10565-019-09473-9 · Cited by 46
Maï, M. E., Marzullo, M., de Castro, I. P., & Ferreira, M. G. (2020) · eLife · doi:10.7554/elife.54935 · Cited by 47
Gutierrez‐Rodrigues, F., Groarke, E. M., Thongon, N., Rodríguez‐Sevilla, J. J., Catto, L. F. B., Niewisch, M. R., Shalhoub, R. N., McReynolds, L. J., Clé, D. V., Patel, B. A., et al. (2024) · Blood · doi:10.1182/blood.2024025023 · Cited by 47
Self-citationPotential of telomerase activation in extending health span and longevity
de Jesus, B. B., & Blasco, M. A. (2012) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2012.09.004 · Cited by 48
Thyrotropin-Releasing Hormone Controls Mitochondrial Biology in Human Epidermis
Knuever, J., Pöeggeler, B., Gáspár, E., Klinger, M. H. F., Hellwig‐Bürgel, T., Hardenbicker, C., Tóth, B. I., Bíró, T., & Paus, R. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1096 · Cited by 45
Safdar, A., Annis, S., Kraytsberg, Y., Laverack, C. A., Saleem, A., Popadin, K. Y., Woods, D. C., Tilly, J. L., & Khrapko, K. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.06.011 · Cited by 44
High fructose causes cardiac hypertrophy via mitochondrial signaling pathway.
Zhang, Y., Meng, Y., Chang, S., Zhang, R., & Chen, S. (2016) · PubMed Central · Cited by 44
Telomere Length Is Associated With Cardiometabolic Factors in US Adults
Mazidi, M., Kengne, A. P., Sahebkar, A., & Banach, M. (2017) · Angiology · doi:10.1177/0003319717712860 · Cited by 44
Wang, Y., Zhang, G., Jiang, F., Zeng, Y., Zou, P., An, H., Chen, Q., Ling, X., Han, F., Liu, W., et al. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.05.004 · Cited by 44
Self-citationPieters, N., Janssen, B. G., Valeri, L., Cox, B., Cuypers, A., Dewitte, H., Plusquin, M., Smeets, K., & Nawrot, T. S. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.02.003 · Cited by 43
The relationship between telomere length and aging-related diseases
Huang, X., Huang, L., Lu, J., Cheng, L., Wu, D. A., Li, L., Zhang, S., Lai, X., & Xu, L. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01608-z · Cited by 57
Osteoarthritis year 2011 in review: biology
Lotz, M. (2011) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2011.11.015 · Cited by 43
Peroxisome proliferator‐activated receptor‐γ cofactors in neurodegeneration
Katsouri, L., Blondrath, K., & Sastre, M. (2012) · IUBMB Life · doi:10.1002/iub.1097 · Cited by 46
Metadata
- Authors
- Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., Maser, R. S., Tonon, G., Foerster, F., Xiong, R., Wang, Y. A., Shukla, S. A., Jaskelioff, M., Martin, E. S., Heffernan, T. P., Protopopov, A., Ivanova, E., Mahoney, J. E., Kost-Alimova, M., Perry, S. R., Bronson, R., Liao, R., Mulligan, R., Shirihai, O. S., Chin, L., & DePinho, R. A.
- Affiliations
- Dana-Farber Cancer Institute (US)
- Harvard University (US)
- Boston University (US)
- Brigham and Women's Hospital (US)
- University of Massachusetts Chan Medical School (US)
- The University of Melbourne (AU)
- Corresponding author
- DePinho, Ronald A.
- ORCID
- Sahin, Ergün
- Colla, Simona
- Liesa, Marc
- Moslehi, Javid
- Müller, Florian L.
- Kotton, Darrell
- Walkey, Carl
- Tonon, Giovanni
- Foerster, Friedrich
- Wang, Y. Alan
- Shukla, Sachet A.
- Jaskelioff, Mariela
- Martin, Eric S.
- Heffernan, Timothy P.
- Protopopov, Alexei
- Ivanova, Elena
- Mahoney, John E.
- Bronson, Roderick
- Liao, Ronglih
- Shirihai, Orian S.
- DePinho, Ronald A.
- Venue
- Nature
- Published
- 2011-02-09
- Volume
- 470
- Issue
- 7334
- Pages
- 359-365
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3741661
- OpenAlex
- W2124098526
- Semantic Scholar
- 14115a60df726b2a29c3a0b4d83e9f284c2371bb
- Cited by
- 1,319
- References
- 49
- Citations by year
- 2026: 50 · 2025: 58 · 2024: 73 · 2023: 87 · 2022: 83 · 2021: 100 · 2020: 78 · 2019: 84 · 2018: 81 · 2017: 88 · 2016: 91 · 2015: 93 · 2014: 83 · 2013: 94 · 2012: 111
- FWCI
- 76.58
- Type
- journal article
- Language
- en
- Update notices
- erratum (2011-06-22)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- National Cancer Institute (R01CA084628)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK035914, R01DK089185, U24DK59635, P30DK046200, U24DK059635, R01DK063356, R01DK056690, P30DK079638)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- telomere dysfunction, p53, PGC-1α, PGC-1β, telomerase reverse transcriptase, telomerase RNA, mitochondrial biogenesis, mitochondrial dysfunction, gluconeogenesis, cardiomyopathy, reactive oxygen species, cellular senescence, hematopoietic stem cells, liver, heart, aging, transcriptional repression
- MeSH terms
- Adenosine Triphosphate, Aging, Animals, DNA, Mitochondrial, Doxorubicin, Gluconeogenesis, Hematopoietic Stem Cells, Liver, Mitochondria, Cardiomyopathies, Myocardium, RNA, Transcription Factors, Tumor Suppressor Protein p53, Telomere, Reactive Oxygen Species, Telomerase, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
